PRODUCT FEATURES

  • DERMALACZYN® has a randomized, placebo-controlled clinical trial (RCT), which demonstrates significant reduction in clinical symptoms of atopic dermatitis in children;
  • The product has additional 3 RCTs published demonstrating improvements of other allergy symptoms;
  • Stimulating the Th1 immune response (INF-γ) and reducing key mediators (IL-4 & IgE) of allergic response
  • The Vitamin D included on its formulation helps modulates the immune response and also helps alleviating symptoms of atopic dermatitis;

PRODUCT CHARACTERISTICS

Indications

DERMALACZYN®   is a natural solution to add on the therapy of Atopic Dermatitis, in order to help reducing the symptoms and improving quality of life in children or adults suffering from AD.

Presentation

DERMALACZYN® is presented in a box with 30 lozenges or box with 30 sachets (powder).

How to use

  • Presentation lozenges:
    • for children above 3 years of age
    • once a day
  • Presentation in sachets (powder)
    • children under 3 years of age
    • once a day
  • It can be combined with emollient & topical corticosteroids

Additional Information

DERMALACZYN® has a shelf life of 24 months.

DERMALACZYN® is a product approved and registered in the EU as a Food Supplement.

BENEFITS AND ADVANTAGES OF DERMALACZYN®

  • Targeting the most frequent allergic disease in children
  • Unique combination of patented probiotic strains specifically selected for the treatment of atopic dermatitis and for restoring the allergic immune system
  • The addition of Vitamin D helps to improve the normal function of the immune system and inflammatory response
  • 50% less allergy symptoms (pruritus, sleep loss, redness, swelling)
  • Less emotional stress
  • Alternative or add-on therapy to corticosteroids
  • Clinically tested in children
  • High acceptance in children
  • Pharmacy exclusive
AEI24 © Copyright 2020